Dr Luke McDonagh is quoted in the 13th July issue of Nature in a feature article - “The Radical plan for vaccine equity”. The article concerns the WHO mRNA hub in South Africa which aims to use an open-science model to build medicine and vaccine capacity in the global south. Dr McDonagh is quoted in the following passage:
'Even if the hub fails in its mission, it is bound to be revealing as a bold experiment testing whether an open-science model can build capacity. This is not without precedent. In the 1960s and 1970s, West Germany, Switzerland and Japan all built up their biotechnology sectors with public funding, and didn’t enforce patents until the industry was mature. “That’s kind of been the development model for how the West got to be where it is, and where China was until recently,” explains Luke McDonagh, an IP researcher at the London School of Economics and Political Science. He and other researchers even predict that this model can result in more innovation through collaboration.'
The full article is available here.